Home / Health / Iron Drips Transform Maternal Anemia Care in India
Iron Drips Transform Maternal Anemia Care in India
19 Jan
Summary
- IV iron supplementation offers solution to poor oral tablet compliance in pregnant women.
- New single-dose IV iron supplement has become affordable after patent expiry.
- Anemia rates increased in children and women, including pregnant women, in India.

In India, a significant rise in anemia among pregnant women has prompted states like Rajasthan and Karnataka to adopt intravenous (IV) iron supplementation as a critical intervention. This approach addresses the persistent issue of poor compliance with oral iron and folic acid tablets, often exacerbated by unpleasant side effects. The recent availability of a more affordable single-dose IV iron supplement, Ferric Carboxymaltose (FCM), following its patent expiry in 2023, has made this treatment a viable option for public health programs.
The new IV FCM supplement offers improved outcomes for both mothers and infants by effectively correcting anemia. Rajasthan initiated a pilot program after studies demonstrated FCM's efficacy, while Karnataka is rolling it out across multiple districts. A digital application, Garbha Sutra, has also been launched to assist healthcare providers in calculating precise dosages based on individual patient metrics, ensuring targeted treatment.



